DALL'ARMELLINA, SARA
DALL'ARMELLINA, SARA
SCIENZE MEDICHE
Comparison of Digital versus Analog 68Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment
2023-01-01 Rovera, Guido; Grimaldi, Serena; Dall'Armellina, Sara; Zotta, Michela; Finessi, Monica; Passera, Roberto; Deandreis, Désirée
COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses-a Pitfall in [18F]FDG PET/CT
2021-01-01 Liberini, Virginia; Grimaldi, Serena; Huellner, Martin W; Giunta, Francesca; Bachi, Costanza; Dall'Armellina, Sara; Onesti, Federica; Ceci, Francesco; Boccomini, Carola; Icardi, Massimiliano; Deandreis, Désirée
Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy
2022-01-01 Ceci F.; Rovera G.; Iorio G.C.; Guarneri A.; Chiofalo V.; Passera R.; Oderda M.; Dall'Armellina S.; Liberini V.; Grimaldi S.; Bello M.; Gontero P.; Ricardi U.; Deandreis D.
Predictors of Bone Metastases at68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence
2022-01-01 Rovera G.; Grimaldi S.; Dall'armellina S.; Passera R.; Oderda M.; Iorio G.C.; Guarneri A.; Gontero P.; Ricardi U.; Deandreis D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Comparison of Digital versus Analog 68Ga-PSMA-11 PET/CT Performance in Hormone-Sensitive Prostate Cancer Patients with Early Biochemical Recurrence or Persistence after Radical Treatment | 2023 | Rovera, Guido; Grimaldi, Serena; Dall'Armellina, Sara; Zotta, Michela; Finessi, Monica; Passera, Roberto; Deandreis, Désirée | |
| COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses-a Pitfall in [18F]FDG PET/CT | 2021 | Liberini, Virginia; Grimaldi, Serena; Huellner, Martin W; Giunta, Francesca; Bachi, Costanza; Dall'Armellina, Sara; Onesti, Federica; Ceci, Francesco; Boccomini, Carola; Icardi, Massimiliano; Deandreis, Désirée | |
| Event-free survival after 68 Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy | 2022 | Ceci F.; Rovera G.; Iorio G.C.; Guarneri A.; Chiofalo V.; Passera R.; Oderda M.; Dall'Armellina S.; Liberini V.; Grimaldi S.; Bello M.; Gontero P.; Ricardi U.; Deandreis D. | |
| Predictors of Bone Metastases at68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence | 2022 | Rovera G.; Grimaldi S.; Dall'armellina S.; Passera R.; Oderda M.; Iorio G.C.; Guarneri A.; Gontero P.; Ricardi U.; Deandreis D. |